| EPC323 | 'I was scared dating… who would take me with my status?' Living with HIV in the UTT era in Johannesburg, South Africa | E-poster | Measuring and enhancing retention and adherence in HIV prevention programmes |
| EPC324 | Geographic disparities in HIV PrEP pharmacy reversals, a novel observational data indicator of PrEP non-adherence | E-poster | Measuring and enhancing retention and adherence in HIV prevention programmes |
| EPC325 | Putting 2+1+1 into practice: MSM PrEP users' knowledge about safely starting and stopping PrEP in Belgium | E-poster | Measuring and enhancing retention and adherence in HIV prevention programmes |
| EPC326 | Association of patient Out-of-Pocket costs with HIV Pre-Exposure Prophylaxis (PrEP) pharmacy reversals, a novel measure of PrEP non-adherence, and abandonments | E-poster | Measuring and enhancing retention and adherence in HIV prevention programmes |
| EPC327 | Understanding and addressing barriers to pre-exposure prophylaxis (PrEP) continuation among vulnerable adolescent girls and young women in Namibia | E-poster | Measuring and enhancing retention and adherence in HIV prevention programmes |
| EPC328 | Linking PLHIV lost to follow-up back to care in 5 regions of the Russian Federation | E-poster | Measuring and enhancing retention and adherence in HIV prevention programmes |
| EPC329 | Improving viral load testing uptake for HIV infected cohort on antiretroviral therapy (ART) at a rural setting: lessons learnt from Neno district, Malawi | E-poster | Measuring and enhancing retention and adherence in HIV prevention programmes |
| EPC330 | Comparison of adherence measurement tools used in a pre-exposure prophylaxis demonstration study men who have sex with men in China | E-poster | Measuring and enhancing retention and adherence in HIV prevention programmes |
| EPC331 | Accuracy of PrEP adherence measures among adolescents men who have sex with men and transgender women in Brazil | E-poster | Measuring and enhancing retention and adherence in HIV prevention programmes |
| EPC332 | Utilization of oral pre-exposure prophylaxis (PrEP) after FTC/TAF approval in the United States' | E-poster | Measuring and enhancing retention and adherence in HIV prevention programmes |